Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated October 23, 2025, titled "Press Release: Nanomedic Clears UK NHS Hurdle, Launches India Market Strategy, and Targets US FDA Submission".
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Limited announced that its product/initiative Nanomedic has cleared a regulatory hurdle with the UK National Health Service (NHS). Following this UK milestone, the company is launching a market strategy for India. Additionally, the company has set its sights on filing for US FDA approval, indicating a multi-jurisdictional expansion plan.
Positive near-term sentiment for shareholders as the UK NHS clearance validates the product and opens a major healthcare market. The India market entry and planned US FDA submission suggest potential revenue diversification and long-term growth, though regulatory outcomes remain uncertain.